Some findings suggest that the presence of PTEN loss in the absence of ERG rearrangement associates with the worst outcomes following surgical or conservative therapies in localized PCa [44,132], and larger studies indicate that patients with PTEN loss experience poor outcomes—in terms of BRFS—regardless of ERG status [43,49,137]. The gene discussed is PTEN; the disease is posterior cortical atrophy.